Cargando…
Key-interventions derived from three evidence based guidelines for management and follow-up of patients with HFE haemochromatosis
BACKGROUND: HFE-related hereditary haemochromatosis (HH) is a common autosomal recessive disorder with clinical manifestations ranging from asymptomatic disease to possible life-threatening complications. Cirrhosis, hepatocellular carcinoma, diabetes mellitus or osteoporosis can develop in HH patien...
Autores principales: | Vanclooster, Annick, Wollersheim, Hub, Vanhaecht, Kris, Swinkels, Dorine, Aertgeerts, Bert, Cassiman, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062877/ https://www.ncbi.nlm.nih.gov/pubmed/27733158 http://dx.doi.org/10.1186/s12913-016-1835-2 |
Ejemplares similares
-
Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosis
por: King, Caitriona, et al.
Publicado: (2006) -
A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population
por: Hubacek, J.A., et al.
Publicado: (2023) -
Hæmochromatosis
Publicado: (1936) -
A CASE OF HÆMOCHROMATOSIS.—THE RELATION OF HÆMOCHROMATOSIS TO BRONZED DIABETES
por: Opie, Eugene L.
Publicado: (1899) -
Haemochromatosis revisited
por: Alvarenga, Aline Morgan, et al.
Publicado: (2022)